Research ArticleCancer

Application of a MYC degradation screen identifies sensitivity to CDK9 inhibitors in KRAS-mutant pancreatic cancer

See allHide authors and affiliations

Science Signaling  16 Jul 2019:
Vol. 12, Issue 590, eaav7259
DOI: 10.1126/scisignal.aav7259

Log in to view Figures & Data

Log in through your institution

Log in through your institution

Stay Connected to Science Signaling